Carlos Marcelo Nicolas Rivolta

Carlos Marcelo Nicolas Rivolta is a distinguished inventor based in South Yorkshire, GB. He has made significant contributions to the field of regenerative medicine, particularly in the identification and isolation of human otic progenitor cells. With a total of three patents to his name, Rivolta's work is paving the way for advancements in hearing restoration and related therapies.

Latest Patents

Rivolta's latest patents focus on the identification and isolation of human otic progenitor cells. The inventions detail methods for using specific cell markers to identify and isolate these progenitor cells from mixed populations. The patents also describe methods for enriching and producing human otic progenitor cells, along with associated kits designed for their identification and isolation. The cell markers utilized in these methods include SSEA1 (CD15), disialoganglioside GD3, TRA-2-49, SSEA4, ganglioside GD2, and CD141.

Career Highlights

Carlos Marcelo Nicolas Rivolta is affiliated with The University of Sheffield, where he conducts his research and development activities. His work has garnered attention for its potential applications in regenerative medicine and hearing restoration. Rivolta's innovative approaches are contributing to a deeper understanding of otic progenitor cells and their capabilities.

Collaborations

Rivolta collaborates with notable colleagues, including Sarah Louise Boddy and Darrell Michael Barrott. These partnerships enhance the research efforts and broaden the scope of their collective work in the field.

Conclusion

Carlos Marcelo Nicolas Rivolta is a prominent figure in the realm of human otic progenitor research, with a focus on innovative methods for cell identification and isolation. His contributions are vital for future advancements in regenerative medicine and hearing restoration therapies.

This text is generated by artificial intelligence and may not be accurate.